Lee, Danner & Bass’s DexCom DXCM Stock Holding History

Lee, Danner & Bass’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22	Closed	-$1.71K	–	347
2024 Q4	$1.71K	Buy	+22	New	+$1.63K	﹤0.01%	691

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Lee, Danner & Bass's DXCM Position: Q1 2025 in Review

Lee, Danner & Bass sold out of DexCom (DXCM) in Q1 2025, closing a stake of 22 shares — an estimated $1.71K sold.

Lee, Danner & Bass first reported a position in DXCM in Q4 2024 and held it in 1 quarter. The position peaked at $1.71K in Q4 2024. 932 funds tracked by Wall St. Rank hold DXCM as of Q1 2025.

Lee, Danner & Bass reported no remaining DexCom position as of Q1 2025 after selling out during the quarter.
Lee, Danner & Bass sold 22 DexCom shares in Q1 2025, an estimated $1.71K.
Lee, Danner & Bass first reported a position in DexCom in Q4 2024 and held it in 1 quarter.
Lee, Danner & Bass's DexCom position peaked at $1.71K in Q4 2024.
932 funds tracked by Wall St. Rank held DexCom as of Q1 2025.

Based on Lee, Danner & Bass's 13F filing for Q1 2025, filed 29 Apr 2025.